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Published by Elsevier Inc. doi:10.1016/j.jacc.2011.01.018This review is a sequel to our 6 previous reports highlighting
the most important published research regarding single
photon-emission computed tomography (SPECT), myo-
cardial perfusion imaging, cardiac positron emission tomog-
raphy (PET), cardiac computed tomography (CT), and
cardiac magnetic resonance imaging (MRI). This report
covers the English-language research between July 1, 2009,
and June 30, 2010. At the suggestion of the editors, we have
chosen to be more selective in our coverage and to provide
more in-depth discussion of fewer reports. We continue to
believe that an integrated, multimodality imaging approach
is optimal for the solution of clinical problems, and we have
organized the summary around topical themes.
Technical Developments
SPECT. Despite its proven clinical utility, SPECT myo-
cardial perfusion imaging has major technical limitations:
low count rates, suboptimal spatial resolution, and relatively
long imaging acquisition times. Newer technology based on
solid-state cadmium telluride crystals offers promise to
address these deficiencies. During this past year, Sharir et al.
(1) reported a larger multicenter study comparing images
acquired with a new high-speed camera based on this crystal
technology with images from conventional SPECT cameras
in 238 patients at 4 different U.S. centers.
The total quantitative perfusion defect size at stress and
rest correlated closely using both the high-speed SPECT
camera and the conventional SPECT camera (r  0.95 and
0.97, respectively). There was also good concordance in the
3 vascular territories (kappa 0.70 for all 3 territories).
Bland-Altman analysis showed modest differences in total
perfusion defect size between high-speed SPECT and
conventional SPECT (Fig. 1). The average amount of
ischemia by high-speed SPECT in high-likelihood patients
was significantly larger than by conventional SPECT, but
there was no comparison with coronary angiography or
outcomes. In a perceptive accompanying editorial, Wackers
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2010, accepted January 2, 2011.(2) described the promise of this new camera and empha-
sized the importance of further studies with external vali-
dation using coronary angiography and clinical outcomes.
CT. Rapid advances in CT technology continue. The
addition of detector rows in multidetector CT makes
acquisitions faster, as larger imaging fields are covered in
each gantry rotation. Last year, a 320-detector row scanner
was introduced, which has a wide enough detector array that
the entire heart can be covered in 1 gantry rotation with no
table movement. This allows for decreased scan times,
though at the potential cost of decreased image quality
because of increased scatter.
In a feasibility study, Dewey et al. (3) performed coronary
computed tomographic angiography (CTA) in 30 patients
scheduled for clinically indicated invasive coronary angiog-
raphy. Their 320-detector row CTA technique showed
excellent sensitivity and specificity on both a per patient and
a per segment basis. The average coronary CTA radiation
dose was low at 4.2 mSv, which was lower than the average
radiation dose of invasive angiography, which was 8.5 mSv
(p  0.05). Coronary CTA also required less contrast than
invasive angiography (80 ml vs. 111 ml, p 0.001). Patients
all underwent beta-blockade to heart rates 65 beats/min.
The small study group was composed of relatively young
(mean age 61 years), relatively lean (mean body mass index
26 kg/m2), stable outpatients. Nevertheless, this study
showed promise for the use of 320-detector coronary CTA
as a possible method for reducing radiation dose while
producing diagnostic images.
MRI. In MRI, the strength of the signal is proportional to
the scanner’s magnetic field strength. Higher field strength
(3.0-T) MRI scanners have had clinical application in
neurologic and musculoskeletal imaging. However, in car-
diac imaging, higher field strengths have been associated
with a variety of challenges and limitations, including
electrocardiographic (ECG) gating. The scanner’s magnetic
field causes interference with the ECG signal. This is
accentuated at higher field strengths and has made ECG
gating problematic.
To solve this problem, Frauenrath et al. (4) created an
MRI cardiac gating system that triggers from acoustic heart
tones rather than electrical signal. In 10 volunteers, they
performed several cardiac MRI acquisitions at 3.0-T and
found that their acoustic gating system produced fewer
artifacts from mistriggered gating than an ECG-gated
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The Year in Cardiac Imaging April 26, 2011:1721–34system. However, even if cardiac gating is solved, a variety
of other MRI artifacts are accentuated at 3.0-T compared
with 1.5-T. For widespread clinical cardiac application,
these will have to be addressed.
Patient Safety
General radiation risk. The public health implications of
the growth of imaging procedures using ionizing radia-
tion were brought to attention in a landmark study by
Fazel et al. (5) that we reported last year. A phantom
study by Einstein et al. (6) demonstrated the importance
of using current tissue-weighting factors and appropriate
conversion coefficients to avoid underestimation of the
radiation dose.
CT. In response to the public concern about radiation,
ractitioners of cardiac CT have sought to reduce the
adiation dose for the procedure. This year, 3 distinct
echniques for radiation dose reduction were prominent: 1)
rospective ECG triggering; 2) high-pitch scanning; and 3)
Figure 1 High-Speed SPECT Versus Conventional SPECT
Bland-Altman plots comparing high-speed single photon-emission computed tomog
of the left ventricle is shown for stress (A) and rest (B), comparing conventional S
from Sharir et al. (1).ube voltage reduction. bPROSPECTIVE ECG TRIGGERING. Prospective ECG triggering
s a sequential technique that uses the ECG tracing to initiate
cquisition of a single, nonhelical CT dataset of the heart.
epending on the coverage in each rotation, several acquisi-
ions may be needed to cover the entire heart. Because the
-ray beam is on only during the cardiac phase of interest,
adiation doses using this technique are much lower than
onventional retrospective ECG-gated techniques.
Bischoff et al. (7) evaluated the potential impact of
rospective ECG triggering on radiation dose and image
uality. Radiation dose was reduced significantly (Fig. 2).
ubsequent image quality was preserved. Patients studied
ith prospective triggering had significantly lower heart
ates than patients studied with retrospective gating, dem-
nstrating a potential limitation of prospective ECG trig-
ering: it is typically more heart rate dependent than
etrospective gating. As prospective triggering gains accep-
ance in clinical practice, patients with high heart rates,
articularly those who cannot be rate controlled, may
(SPECT) and conventional SPECT. The total perfusion defect (TPD) as a percent
and high-speed SPECT. The differences are modest. Reprinted, with permission,raphy
PECTecome a concern.
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April 26, 2011:1721–34 The Year in Cardiac ImagingHIGH-PITCH SPIRAL CTA. High-pitch CTA is another tech-
ique in cardiac CT that relies on prospective triggering
rom the ECG signal to reduce radiation dose. The main
ifference between this technique and other prospectively
riggered techniques is that a helical, rather than sequential,
T acquisition is performed during a single R-R interval,
ather than across multiple heart beats.
The key to this recent innovation is a dual-tube and
etector array system that can be operated at very high-pitch
ettings (3.0 to 3.4) compared with conventional systems.
canning at very high pitch allows coverage of the entire
eart in under 300 ms with no scan overlap. Radiation
Figure 2 Reduced Radiation With Prospective Triggering
(A) Box-and-whisker plot of dose-length product (radiation dose) with retrospec-
tive electrocardiographically gated technique (helical scanning) shows signifi-
cantly increased radiation compared with prospective triggering (sequential
scanning). (B) Subjective image quality is not significantly different between
the 2 techniques. Reprinted, with permission, from Bischoff et al. (7).xposure is therefore much lower. Achenbach et al. (8) vvaluated image quality and radiation dose in 50 consecutive
atients with coronary CTA performed using high-pitch
canning. Using a subjective assessment of coronary artery
mage quality, they found overall excellent image quality in
4% of coronary artery segments (694 of 742); only 4
egments in 3 patients were unevaluable. Unfortunately,
ore than one-fourth (19 of 69) of the patients initially
onsidered for the study had to be excluded because of heart
ate or weight. Estimated radiation dose was1 mSv (range
.78 to 0.99 mSv) in all patients (Fig. 3).
PROSPECTIVE ECG TRIGGERING IN CLINICAL PRACTICE. Not
all patients encountered in clinical practice have stable, low
heart rates, and not all patients with elevated heart rates will
tolerate or respond to pharmacologic rate control.
Pflederer et al. (9) tried to address this limitation using a
staged protocol. Patients whose prospectively triggered cor-
onary CT angiograms were not of diagnostic quality re-
ceived additional conventional spiral CT scans. Although
roughly one-fifth of the patients randomized to the pro-
spective ECG gated group required repeat scanning (11 of
56), the overall radiation dose to this group was still
significantly lower than that to the control group, which
underwent single retrospectively gated CT scans. This
staged approach is a potential real-world solution to a
common clinical problem. However, the patients in this
study who required repeat scanning received approximately
75 ml of extra contrast media, which would limit this
approach in patients with renal dysfunction.
TUBE VOLTAGE REDUCTION. Another approach to decrease
T radiation dose is reduction of tube voltage. Previously,
ypical tube voltage settings for normal-sized adult patients
ad been about 120 kV. However, several recent studies
ave shown that adequate image quality can be attained
sing reduced tube voltage settings of about 100 kV. The
ower energy photons used by this technique have the added
enefit of increasing the visualization of iodinated contrast
nd thereby improving image quality.
In a subgroup analysis, Bischoff et al. (10) compared
adiation dose and image quality of coronary CT angio-
rams performed at 100 kV (n  82) to coronary CTA
erformed at 120 kV (n 239). As expected, radiation dose
as significantly lower using the reduced tube voltage,
pproximately 6 mSv for the 100-kV setting compared with
4 mSv for the 120-kV scans. Although image noise
ncreased by 26.3% for the lower voltage scans, signal
ntensity also increased; signal-to-noise ratios were there-
ore equivalent between the 2 groups. Of more importance,
he investigators found no difference in image quality.
ecause patients were not prospectively randomized be-
ween the 2 groups, the patients in the 100-kV group had
ower body weights and body mass indexes than those in the
20-kV group. Lower energy photons have less penetrating
ower than those produced at higher energy; the investiga-
ors therefore recommended restricting the use of low-
oltage tube current to nonobese patients.
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CT. ADENOSINE STRESS MYOCARDIAL IMAGING USING CT.
Although cardiac CT has gained acceptance in recent years
as a test for the assessment of obstructive coronary artery
disease (CAD), the physiologic significance of a strictly
anatomic finding has been debated. The potential ability of
CT to provide both anatomic and physiologic information
has been evaluated previously. This year, 2 studies added to
those data by combining adenosine-induced stress perfusion
imaging with coronary CTA.
In 35 patients with high suspicion of coronary athero-
sclerosis, Rocha-Filho et al. (11) evaluated the ability of
CTA and adenosine stress perfusion CT, both alone and in
combination, for the diagnosis of obstructive coronary
disease on invasive coronary angiography. First, the CTA
images were graded for stenosis (mild [50%], moderate
[50% to 69%], or severe [70%]). Then the adenosine stress
and rest CT images were evaluated for perfusion defect
extent and reversibility (fixed, partially reversible, or com-
pletely reversible). Finally, the readers were allowed to
reclassify the lesions they had initially graded based on CTA
images alone. During this final step, vessels previously
graded as uninterpretable were considered diseased only if
there was a corresponding perfusion defect in the appropri-
Figure 3 Image Quality With Radiation-Reducing High-Pitch Sc
Electrocardiographically triggered high-pitch coronary computed tomographic angiog
ing coronary artery (arrows), (B) the right coronary artery (arrows), and (C) the le
to that seen on invasive angiography (D, stenosis at arrow). The radiation dose fo
graph. Reprinted, with permission, from Achenbach et al. (8).ate vascular territory.The initial diagnostic performance of coronary CTA to
detect 50% stenosis on invasive angiography was as follows:
sensitivity 83%, specificity 71%, positive predictive value
66%, and negative predictive value 87%. After reclassifica-
tion based on the perfusion data, each of these metrics
improved (sensitivity 91%, specificity 91%, positive predic-
tive value 86%, and negative predictive value 93%). The area
under the receiver-operating characteristic curve also im-
proved significantly, from 0.77 to 0.90 (p  0.003). Find-
ings were similar for the detection of 70% stenosis: all
parameters of diagnostic performance improved after reclas-
sification. These gains were present on both a per vessel and
a per patient basis but more impressive on a per vessel basis.
The investigators took all appropriate steps to limit radia-
tion exposure, including using prospective triggering for the
resting CTA, tube current modulation for the stress perfu-
sion study, and appropriate tube voltage for both portions.
The total effective radiation dose for the combined study
was 11.8 4.5 mSv, which is similar to published estimated
dose levels for conventional retrospective ECG-gated cor-
onary CTA. Of the 768 subjects eligible for enrollment in
the study, almost one-half (n  356) declined. An addi-
tional 294 patients were excluded because of an inability to
comply with or tolerate some part of the scan protocol. For
g
shown with curved multiplanar reconstruction of (A) the left anterior descend-
mflex coronary artery (arrows). The stenosis seen at the arrow in C corresponds
study was 0.84 mSv, which is comparable with the dose from a chest radio-annin
ram is
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r thisthis protocol to gain widespread clinical acceptance, a larger
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April 26, 2011:1721–34 The Year in Cardiac Imagingproportion of eligible patients will need to be able to
participate.
The same research group also compared adenosine-
induced stress myocardial perfusion CT with conventional
nuclear stress testing. Blankstein et al. (12) used a similar
CT protocol to that described above, with the addition of a
delayed prospective ECG-triggered CT 7 min after contrast
administration for the detection of delayed hyperenhance-
ment. The investigators again took appropriate steps to
limit radiation dose. The total effective radiation dose from
their CT protocol (including the delayed images) was 12.7 4.0
mSv. The SPECT studies, performed with 10 mCi of
99mTc sestamibi for the rest study and 30 mCi 99mTc
estamibi for the stress study, had a similar total effective
adiation dose (12.7  0.4 mSv, p  0.99).
Although the stress/rest CT protocol was not optimized
or visualization of the coronary arteries (heart rates were
igh and nitroglycerin was not administered), diagnostic
ccuracy for the detection of obstructive coronary artery
tenosis was very similar to that of SPECT. The sensitivity
nd specificity of CT for stenosis70% on invasive angiog-
aphy were 94% (range 71% to 100%) and 41% (range 18%
o 67%), respectively, on a per patient basis. Sensitivity and
pecificity values for SPECT were exactly the same. On a
er vessel basis, the sensitivity and specificity of CT for
tenosis 70% were 86% (range 65% to 97%) and 68%
range 56% to 78%), respectively, compared with 73%
range 50% to 89%) and 73% (range 61% to 82%) for
PECT. In addition, on a per patient basis, the ability of
T delayed enhancement to detect resting perfusion defects
n SPECT was reasonable, with sensitivity of 82%, speci-
city of 81%, positive predictive value of 82%, and negative
redictive value of 81%.
rognosis
RI. PATIENTS WITH AND WITHOUT CAD. MRI delayed
enhancement is an accepted measure of myocardial fibrosis,
whether from infarction or from other causes. Several small
studies have previously shown that the presence and amount
of delayed enhancement are prognostically significant in
specific populations, such as patients with dilated cardiomy-
opathy. In a much larger study this past year, Cheong et al.
(13) studied 857 patients, some with CAD and some with
a variety of cardiomyopathies, who underwent cardiac MRI
with delayed enhancement and were followed for a mean of
4.4 years. Delayed enhancement was quantified using a “scar
index,” which was the average transmurality score of the
delayed enhancement over 17 segments.
In both patients with CAD and those without CAD, scar
index was associated with cardiac transplantation and/or
death on both a univariate basis (p  0.0001) and a
multivariate basis (hazard ratio [HR]: 1.26; p  0.0001),
after adjustment for multiple clinical variables (Fig. 4).
Thus, the MRI assessment of scar is prognostically impor-
tant in broad populations.In a population of patients with CAD only, Kelle et al.
(14) followed 177 patients with known chronic myocardial
infarction (MI) for 20.3  13.3 months for all-cause
mortality or new MI. These patients underwent MRI with
delayed enhancement and assessment of wall motion at rest
and with low-dose (10 g/kg) dobutamine. Many variables
ere individually associated with all-cause mortality: left
entricular (LV) ejection fraction (EF) (p  0.026), LV
nd-systolic volume (p  0.002), LV end-diastolic vol-
me (p  0.0004), number of dysfunctional segments at
est (p  0.003), and semiquantitative wall motion score
t rest (p  0.017).
The change in wall motion score from rest to low-dose
stress was not predictive of overall events in their chronic
MI population (p  0.134). However, in the subpopulation
of patients with large infarcts (6 segments), the improve-
ment in wall motion score from rest to stress (i.e., contrac-
tile reserve) was associated with increased events on univar-
iate analysis (p  0.008). This is consistent with previous
published research using other modalities: in patients with
ischemic cardiomyopathy, the event rate is increased if there
is demonstrable viable myocardium that is not treated with
revascularization (15). In addition, patients with large infarcts
had lower event-free survival compared with those with smaller
infarcts, which is consistent with previous research showing
worse survival with increasing infarct size (16).
Steel et al. (17) followed 254 patients with stable angina
who underwent clinical adenosine stress MRI myocardial
perfusion imaging for a mean of 17 months (range 8 months
to 4.7 years). The presence of an MRI-demonstrated
reversible perfusion defect was associated with the com-
bined endpoint of cardiac death or MI on both univariate
Figure 4 Event-Free Survival and DE by Cardiac MRI
Kaplan-Meier survival curves were created for the combined endpoint of death
or cardiac transplantation for 857 patients. Patients who showed any delayed
enhancement (DE) by magnetic resonance imaging (MRI) had lower event-free
survival than patients who showed no delayed enhancement (DE). Modified,
with permission, from Cheong et al. (13).(p  0.0001) and multivariate analysis (HR: 10.92; p 
riate im
v ricular t
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sex, clinical risk factors, and LVEF. Likewise, delayed
enhancement also showed univariate (p  0.0001) and
multivariate (HR: 8.09; p  0.0001) association with death
or MI.
HYPERTROPHIC CARDIOMYOPATHY. Three separate retro-
spective studies examined the relationship of delayed en-
hancement to outcomes over a mean of about 3 years in
hypertrophic cardiomyopathy (Table 1) (18–20). All 3
studies found a significant univariate association between
delayed enhancement and outcome. Bruder et al. (18) and
O’Hanlon et al. (19) found multivariate association with
their endpoints, and Rubinshtein et al. (20) did a limited,
sequential bivariate analysis. The findings of all 3 studies
suggest that MRI delayed enhancement may eventually be
incorporated into recommendations for implantable
cardioverter-defibrillator (ICD) placement in hypertrophic
cardiomyopathy.
ACUTE MI. Last year, several investigators studied infarct
size and measures of microvascular obstruction by MRI to
predict subsequent adverse remodeling after acute MI
(21,22). This year, several studies used MRI measures of
myocardial salvage to predict events, particularly after ST-
segment elevation MI (STEMI). In these patients, the
myocardium at risk is defined as edematous myocardium
detected with an MRI sequence (T2-weighted, triple inver-
sion recovery).
Eitel et al. (23) studied 208 patients with STEMI,
performing MRI at baseline and clinical follow-up at 6
months for a combined endpoint of death, reinfarction, and
new congestive heart failure. Using MRI, they defined a
myocardial salvage index as (myocardium at risk infarcted
myocardium)/myocardium at risk. After 6-month follow-
Relationship of Cardiac Magnetic Resonance Imaging Findings to OTable 1 Relationship of Cardiac Magnetic Resonance Imaging
First Author
(Ref #) Year n Follow-Up Adverse O
Bruder et al. (18) 2010 220 3 yrs (range
1.3–5.1 yrs)
D
CD
ICD or SCD
Rubinshtein et al. (20) 2010 424 43 months (range
16–94 months)
D
CD
SCD or ICD
O’Hanlon et al. (19) 2010 217 3.1 1.7 yrs Composite en
unplanned
hospitaliza
sustained
CD  cardiac death; CV  cardiovascular; D  all-cause death; HR  hazard ratio; ICD  approp
entricular ejection fraction; SCD  sudden cardiac death; VF  ventricular fibrillation; VT  ventup, they found that patients with higher myocardial salvageindexes had fewer events on both univariate (p 0.001) and
multivariate (p  0.001) analysis (Fig. 5). Most notably, on
multivariate analysis, the myocardial salvage index remained
associated with events, while 6 other established predictors—
Killip class on admission, Thrombolysis In Myocardial Infarc-
tion flow grade after percutaneous coronary intervention,
LVEF, ST-segment resolution, late microvascular obstruction
by MRI, and infarct size by MRI—were not.
In a similar study, Masci et al. (24) studied the same
myocardial salvage index in 137 patients with STEMI.
They found that myocardial salvage index predicted an
mes in Patients With Hypertrophic Cardiomyopathyngs to Outcomes in Patients With Hypertrophic Cardiomyopathy
es
Number of
Events Univariate Multivariate
20 D
16 CD
2 ICD
% LGE associated with D
(p  0.01), CD
(p  0.001), and SCD
(p  0.01)
Presence of LGE was
associated with CD
(HR: 8.6; p  0.038)
when adjusting for
LVEF, myocardial
mass, and presence of
1 or 2 clinical risk
factors
11 D
6 CD
4 SCD,
4 ICD
LGE associated with
combined endpoint of
SCD or ICD
(p  0.002)
Performed serial bivariate
analysis, combining
presence of LGE with
established risk
factors; presence of
LGE still associated
with combined
endpoint
: SCD,
ICD
LGE associated with
combined endpoint
(HR: 3.367;
p  0.006)
plantable cardioverter-defibrillator discharge; LGE  late gadolinium enhancement; LVEF  left
achycardia.
Figure 5 Magnetic Resonance Imaging
Calculation of Myocardial Salvage
(A) Short-axis, T2-weighted image obtained in patient with recent myocardial
infarction shows increased signal in the anterior wall and septum. This repre-
sents edematous myocardium and has been outlined in red for calculation of
the area at risk. (B) The same short-axis slice is imaged for myocardial
delayed enhancement. In this image, infarcted myocardium appears bright and
is outlined in red for calculation of infarct size. Left ventricular epicardial and
endocardial contours are outlined in yellow, and papillary muscles are outlined
in blue for calculation of myocardial mass. The myocardial salvage index is cal-
culated as (myocardium at risk  infarcted myocardium)/myocardium at risk.
Reprinted, with permission, from Eitel et al. (23).utcoFindi
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April 26, 2011:1721–34 The Year in Cardiac Imagingincrease in LV end-systolic volume at 4 months (odds ratio:
0.64; p  0.001) after adjustment for multiple clinical and
RI parameters.
CT. ACUTE MI. In a noteworthy animal study, Mahnken et
l. (25) showed that myocardial edema could be detected on
oncontrast CT, using MRI as a reference standard (Fig. 6).
his suggests that a myocardial salvage index could possibly
e calculated using CT.
CTA FOR CAD. The prognostic value of coronary CT re-
ains a hot topic. Historically, the majority of the research
n this area has centered on coronary calcification; however,
n recent years, several small studies have examined the
otential prognostic utility of coronary CTA. That trend
ontinued this year with larger studies with longer
ollow-up.
Russo et al. (26) compared the prognostic value of
oronary CTA with that of coronary calcium scoring and
linical risk factors. They followed 441 patients who under-
ent coronary calcium scoring and coronary CTA using
6-detector row CT for an average of just under 3 years
31.9  14.8 months). Patients were evaluated for “hard”
ardiac events (cardiac death, nonfatal MI, and unstable
ngina requiring hospitalization). The patients were
Figure 6 CT Compared With Magnetic
Resonance Imaging for Infarct Size
In a single pig with myocardial infarction created by balloon inflation in the left
circumflex coronary artery, short-axis computed tomographic (CT) images (A, B)
and corresponding magnetic resonance images (C, D) are shown. Noncontrast
CT image (A) shows edematous myocardium as a low-density region (arrows).
The corresponding T2-weighted magnetic resonance image (C) shows edema-
tous myocardium as an area of increased signal (arrows). CT image obtained
10 min after contrast injection (B) shows delayed enhancement (arrows) in the
infarcted myocardium, corresponding to the delayed enhancement magnetic reso-
nance image (D), which also shows infarcted myocardium with increased signal
(arrows). Reprinted, with permission, from Mahnken et al. (25).rouped into 3 categories according to their coronaryalcium scores: 10, 11 to 400, and 400. Grading of the
oronary CT angiograms was somewhat more complicated
ut basically consisted of evaluating each coronary artery
egment for atherosclerotic plaque (none, calcified, noncal-
ified, and mixed) and stenosis (none, 50%, or 50%).
here were a total of 44 hard events during the follow-up
eriod (10%), including 15 cardiac deaths (3.4%), 11 non-
atal MIs (2.5%), and 18 hospitalizations due to unstable
ngina (4.1%).
Patients with normal coronary arteries on coronary CTA
ad a very low rate of hard cardiac events (annualized event
ate 0.88%) compared with patients with any coronary
esions (annualized event rate 3.89%). Obstructive coronary
isease (p  0.003) and the presence of noncalcified or
ixed plaque (p  0.0001) were independent predictors of
ard cardiac events on multivariate analysis. The presence of
oncalcified or mixed plaque improved the prediction of hard
vents (p  0.0001, chi-square  27.07) compared with
calcium score and clinical pre-test likelihood.
van Werkhoven et al. (27) looked at the incremental
prognostic value of coronary CTA compared with coronary
calcium studies alone. They followed 432 patients who
underwent coronary calcium scoring and coronary CTA
using 64-detector row CT for an average of about 2 years.
They used a composite endpoint of all-cause mortality,
nonfatal MI, and unstable angina requiring revasculariza-
tion. Patients were stratified into 5 groups by coronary
calcium score: 0, 1 to 99, 100 to 399, 400 to 999, and
1,000. Coronary CTA results were divided into 3 cate-
gories: 1) normal (which included patients with minimal
wall irregularities but 30% stenosis); 2) nonsignificant
coronary atherosclerosis (coronary artery plaque, but no
stenosis 50%); and 3) significant coronary atherosclerosis
(stenosis 50%). All diseased segments were evaluated for
calcified, noncalcified, and mixed plaque.
There was a total of 21 events (4.9%), including 6 deaths
(1.4%), 8 nonfatal MIs (1.8%), and 7 coronary revascular-
izations for unstable angina (1.6%). Multivariate analysis
demonstrated that extent of disease and plaque characteris-
tics were predictive of cardiac events; specifically, plaque
burden (number of diseased segments) and plaque compo-
sition (number of noncalcified and mixed plaques) provided
incremental prognostic value over clinical variables and
coronary calcium scoring.
Twenty percent of patients with coronary calcium scores
of zero had noncalcified plaque, and 4% of patients with no
coronary calcium had significant CAD (stenosis 50%) by
CTA. Thus, coronary calcification studies alone may not be
adequate to accurately assess prognosis.
Chow et al. (28) studied the prognostic value of coronary
CTA both as a measure of CAD severity and also as a
measure of LVEF in a single examination. A total of 2,076
consecutive patients without histories of coronary revascu-
larization, heart transplantation, or congenital heart disease
underwent coronary CTA on 64-detector row scanners and
were followed for 16  8 months. On the basis of the
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The Year in Cardiac Imaging April 26, 2011:1721–34coronary CTA, patients were classified into 4 categories
of CAD severity: 1) no visible coronary atherosclerosis;
2) nonobstructive atherosclerosis; 3) non– high-risk ob-
structive coronary atherosclerosis; and 4) high-risk obstruc-
tive CAD, which was defined as left main stenosis50% or
2- or 3-vessel stenoses 70% as defined by coronary CTA.
VEF was calculated from CT-derived LV and end-
iastolic and end-systolic volumes.
Overall, there were 34 events, including 11 cardiac
eaths (0.5%) and 23 nonfatal MIs (1.1%). The only
ardiac death in patients with no visible atherosclerosis
as in 1 patient with a primary cardiac neoplasm, which
ed to an event rate of 0.2% (1 of 591) in this group.
hus, lack of visible atherosclerosis on coronary CTA is
ssociated with an excellent prognosis. Multivariate anal-
sis showed that the 4-point CAD severity scoring
ystem by Chow et al. (25) was an independent predictor
f cardiac death or nonfatal MI after adjusting for clinical
haracteristics including National Cholesterol Education
rogram Adult Treatment Panel III risk and pre-test
ikelihood of CAD (p  0.001). As expected, CT-
erived LVEF was also an independent risk factor for
ardiac death or nonfatal MI (p  0.001). Assessment of
ncremental prognostic value showed that CAD severity
ad incremental prognostic value over clinical predictors,
ith an increase in the global chi-square value from 24.97
o 43.81 (p  0.001). LVEF had incremental prognostic
alue over a model including both CAD severity and
linical predictors, with an increase in the global chi-
quare value from 43.81 to 54.48 (p  0.001). This is the
atest in a series of studies showing that a variety of
ariables can be extracted from cardiac CT that give a
arge amount of prognostic information.
SPECT. CHRONIC CAD. The clinical use of stress SPECT
yocardial perfusion imaging is based on a strong evidence
ase supporting its prognostic value. Although most of the
vidence is based on patients who are younger than 75 years
f age, clinical practice is increasingly dominated by older
atients. The published evidence on “elderly” patients,
sually defined as age 75 years or older, was limited to small
tudies until Hachamovitch et al. (29) reported this past year
n 5,200 elderly patients, with 2.8  1.7 years of follow-up
fter stress SPECT. Forty-one percent of the patients
nderwent exercise stress, and 59% underwent pharmaco-
ogic stress. The presence of either ischemic or fixed defects
onveyed a worse prognosis. Patients with normal results
ad a lower rate of subsequent cardiac death, which was
.3% per year. This was higher than the 1% per year that
s commonly associated with normal results and cited in
linical practice guidelines (30), reflecting the advanced age
f the population. However, Hachamovitch et al. (29) were
ble to identify important subsets of patients (e.g., those age
5 to 84 years, those with normal resting ECG results, and
hose undergoing exercise stress) for whom normal results
mplied a 1% per year rate of cardiac death (Fig. 7). In
ontrast, patients age 85 years or older, and those whonderwent pharmacologic stress, had annual cardiac death
ates of 2.3% to 3.7%. Age, perfusion data, and ejection
raction were all independently significant prognostic
actors.
SPECT PERFUSION AND METAIODOBENZYLGUANIDINE (MIBG):
SUDDEN CARDIAC DEATH. Sudden cardiac death remains an
important clinical and public health problem. Although
ICD therapy has improved the survival of patients with
abnormal ejection fractions, the majority of sudden cardiac
deaths still occur in the much larger population of patients
with normal ejection fractions. Piccini et al. (31) published
a provocative analysis of the potential value of stress SPECT
in 4,865 patients with coronary disease and ejection frac-
tions 35% from the Duke databank. During a mean
follow-up period of 6.5 years, there were 161 sudden cardiac
deaths (3.3%). Although the summed stress score was
independently associated with sudden cardiac and added
significantly to the concordance index, a rigorous analysis of
reclassification showed that SPECT data did not add any
significant net reclassification.
Even in patients with abnormal ejection fractions, there is
a need to better identify those who are at the greatest risk
and would therefore benefit the most from ICDs. Previous
efforts focused on QT and heart rate variability, T-wave
alternans, and biomarkers have not achieved success. One
potential approach that has not yet been fully explored is
cardiac imaging with the norepinephrine analog MIBG.
Two important studies during the past year evaluated the
potential value of cardiac MIBG imaging. Boogers et al.
(32) performed MIBG imaging before ICD placement in
116 patients with heart failure, who were then followed for
23 5 months. One hundred three of the ICDs (89%) were
Figure 7 Cardiac Death in the Elderly
The rate of cardiac death for elderly patients, divided into those age 75 to 84
years (white bars) and those age 85 years (black bars) for the U.S. popula-
tion, the overall study cohort, those with normal results on myocardial perfu-
sion studies (MPS), and those with abnormal results on MPS. Significant
differences by age subgroup are indicated by the asterisks. The impact of
advanced age is readily apparent. Reprinted, with permission, from Hachamov-
itch et al. (29).placed for primary prevention; 13 (11%) were placed after
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April 26, 2011:1721–34 The Year in Cardiac Imagingcardiac arrest. The majority of the patients (74%) had
ischemic cardiomyopathies. The MIBG defect score as-
sessed by SPECT on a late (4 h) SPECT scan was
significantly associated with the primary endpoint of appro-
priate ICD discharge on both univariate and multivariate
analysis, but the late MIBG heart-to-mediastinal ratio
(H/M) on planar imaging was not.
Jacobson et al. (33) reported a much larger multicenter
study of MIBG imaging in 961 patients with New York
Heart Association functional class II or III heart failure and
ejection fractions 35%. Patients with previous defibrilla-
tion for cardiac arrest were excluded. The primary analysis
was based on the planar H/M ratio using a prospectively
designated cutoff of 1.6. The primary endpoint was progres-
sion of heart failure, life-threatening arrhythmia, or death.
The H/M ratio had an HR of 0.40 (p  0.01) for this
combined endpoint, as well as an HR of 0.14 (p  0.006)
or the endpoint of cardiac death. However, most patients
80%) had abnormal H/M ratios. Surprisingly, SPECT
IBG defect score was not associated with the primary
ndpoint.
Thus, although both Booger et al. (32) and Jacobson et al.
33) reported positive findings, the 2 studies are inconsistent
ith respect to which MIBG parameter or imaging tech-
ique is most valuable. Further studies are clearly needed
efore widespread clinical application.
tructure and Function
T. PLAQUE CHARACTERIZATION. A majority of MIs occur
s a result of plaque rupture, prompting the search for a
oninvasive method of identifying so-called vulnerable
laque. Various patient populations have been studied by
TA in an attempt to determine the significance of differ-
nt plaque morphology. This year, 3 notable studies evalu-
ted the CT characteristics of coronary lesions in patients
ith known coronary atherosclerosis.
CTA FOR EVALUATION OF THIN-CAP FIBROATHEROMA. Re-
cent studies have suggested that thin-cap fibroatheroma is a
precursor lesion for plaque rupture. Optical coherence
tomography provides a semi-invasive method of detecting
this thin-cap fibroatheroma. Kashiwagi et al. (34) compared
coronary CTA performed with 64-detector row CT with
optical coherence tomography for the detection of thin-cap
fibroatheroma in 105 patients with known CAD (31 with
acute coronary syndromes and 74 with stable angina
pectoris).
Culprit lesions were identified in all patients using a
combination of ECG, echocardiographic, and nuclear scin-
tigraphic findings, in combination with stenotic site by
coronary angiography. Patients were divided into 2 catego-
ries: those with thin-cap fibroatheroma of the culprit lesion
seen by optical coherence tomography (n  25) and those
ithout (n 80), although identifying culprit lesions in this
anner can be problematic. bFindings on coronary CTA that were predictive of
hin-cap fibroatheroma were 1) positive remodeling; 2)
ow-attenuation plaque; and 3) ringlike enhancement. The
rst 2 characteristics confirm the results of previous CT
tudies of coronary plaque. To our knowledge, the associa-
ion of peripheral ringlike enhancement with vulnerable
oronary atheroma has not previously been demonstrated in
ivo in patients by CT, although plaque enhancement or
nflammation has been shown by other modalities, particu-
arly in the carotid arteries (35,36). The pathophysiology of
inglike enhancement is unknown.
A total of 38 patients had to be excluded from the study,
ostly because of heavy coronary calcification that pre-
luded evaluation. If a significant number of patients with
nown CAD are not suitable candidates, the applicability of
his technique in clinical practice would be limited.
TA features of culprit lesions in STEMI and non-STEMI.
uang et al. (37) performed coronary CTA using 64-detector
ow CT in 120 patients with acute coronary syndromes to
xamine differences in culprit lesion plaque morphology be-
ween patients with STEMI (n  54) and those with non–
T-segment elevation myocardial infarction (NSTEMI) (n 
6). As in the prior study, culprit lesions were identified using
combination of imaging modalities with correlation to
nvasive angiography.
Culprit lesions in patients with STEMI were more
tenotic than those in patients with NSTEMI. Culprit
esions in patients with STEMI also exhibited more positive
emodeling than those in patients with NSTEMI, in terms
f both the amount of remodeling per lesion (remodeling
ndex 1.28  0.34 vs. 1.16  0.22, p  0.21) and the total
ercent of culprit lesions exhibiting any positive remodeling
81.5% vs. 63.6%, p  0.031). Although the overall calcium
cores of patients with STEMI and those with NSTEMI
ere not significantly different, patients with STEMI had
n increased total plaque burden (0.91  0.10 vs. 0.84 
.12) and a lower average plaque density (25.8  13.9 vs.
3.5  19.1 Hounsfield units [HU], p  0.001) per lesion
han patients with NSTEMI. However, as in the study by
ashiwagi et al. (34), identifying culprit lesions can be
ifficult, especially when there is more than 1 lesion in a
articular vessel territory. Lesions are often selected in terms
f their morphology, which can bias the results of studies
uch as this one and the one by Kashiwagi et al. (34).
PLAQUE CHARACTERISTICS PREDICT POST-PROCEDURAL
YOCARDIAL INJURY. Uetani et al. (38) used a semiauto-
ated tool for plaque analysis to characterize and quantify
therosclerotic lesions seen on coronary CTA in 189 pa-
ients who subsequently underwent coronary artery stenting.
hey then correlated the CT findings with the presence of
ost-procedural myocardial injury, defined as troponin T
levation0.1 ng/ml, which was seen in 59 patients (31.2%
f the study population).
On 64-detector row CT, the lesions of interest were
easured and plaque composition was determined on theasis of HU values (low-attenuation plaque 50 HU,
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attenuation plaque 500 HU). The arterial lumen was
efined as 151 to 500 HU. The volume of low-attenuation
laque and the portion of total plaque that represented
ow-attenuation plaque were significantly higher in patients
ith post-procedural myocardial injury than in those with-
ut (87.9  94.8 mm3 vs. 47.4  43.7 mm3, p  0.01, and
32.9% vs. 29.0%, p  0.01, respectively). However, there
was significant overlap between the 2 groups.
INCIDENTAL FINDINGS. Incidental, noncardiac findings on
mages obtained during cardiac CT continue to be of
nterest. This year, 2 studies examined the potential impor-
ance of these findings in much larger populations than
reviously reported. Johnson et al. (39) evaluated coronary
T angiograms from 6,920 consecutive patients and found
t least 1 extracardiac finding in 1,642 (23.7%), 1,119 of
hich (16.2% of the total group) were significant enough to
equire therapy or additional testing. In 99 patients, imme-
iate therapy was required to treat significant medical
onditions; new diagnoses of malignancy were made in 5
atients.
Kim et al. (40) performed a retrospective review of 12,268
ardiac CT scans performed on 11,176 patients and found
1 patients with lung cancer, 36 of whom had initial
iagnoses by cardiac CT. Of these 36, 32 (89%) would not
ave been detected using a limited field of view (16 to 18
m), sometimes recommended for coronary CT (Fig. 8).
RI. LV VOLUMES AND MASS. MRI can measure cardiac
olumes very precisely. Because MRI uses no ionizing radi-
tion, it can be used in large population studies, such as MESA
Multi-Ethnic Study of Atherosclerosis), an ongoing multi-
enter study of subjects with subclinical atherosclerosis.
Although severe chronic obstructive pulmonary disease is
nown to lead to elevated pulmonary vascular resistance,
ith an associated decrease in LV filling, the effect of
onsevere lung disease on LV function is not known. In
,816 subjects, Barr et al. (41) compared LV volumes by
RI with emphysema quantified on CT scans in subjects
Figure 8 Disadvantages of Limited-FOV Reconstruction
Axial cardiac computed tomographic images in a 63-year-old man reconstructed
with (A) limited field of view (FOV) and (B) full FOV. A spiculated nodule consis-
tent with malignancy is visible only in the full-FOV reconstruction (arrows in B).
Reprinted, with permission, from Kim et al. (40).ithout severe lung disease. On average, the patients had5% of their lungs affected by emphysema on CT but
ormal average spirometric lung function. Increasing em-
hysema score by CT was associated with decreased LV
nd-diastolic volume, end-systolic volume, and cardiac out-
ut as measured by MRI; the strength of the association was
reater for smokers.
Thus, subclinical changes in lung architecture, possibly
eading to a loss of the pulmonary capillary bed, were
ssociated with subclinical abnormal LV filling.
DIASTOLIC FUNCTION. MRI has long been used for the
evaluation of systolic function using LVEF and regional
wall motion. More recently, MRI has been used to evaluate
diastolic function, using either measurements of flow
through the mitral valve, as is done in echocardiography, or
LV volume curves, as is done with nuclear methods. Several
investigators used various MRI parameters to evaluate
patients with diastolic dysfunction.
Patel et al. (42) studied 201 patients with end-stage renal
disease with LV hypertrophy by MRI and followed them for
3.6 years (range 1.2 to 5.2 years) for all-cause mortality. The
investigators measured left atrial volume from magnetic
resonance images using the biplane area-length method.
Increasing left atrial volume was individually significantly
associated with increased all-cause mortality (p  0.01). In
multivariate analysis, left atrial volume remained associated
with all-cause mortality (HR: 1.06; p  0.009), along with
LVEF (HR: 1.77; p 0.05), the presence of ischemic heart
disease (HR: 2.73; p  0.001), and kidney transplantation
(HR: 0.22; p  0.001).
Left atrial enlargement in these patients may be caused by
diastolic dysfunction and chronic fluid overload; the inves-
tigators suggested its use as a prognostic marker in patients
with end-stage renal disease. Echocardiographic left atrial
volume has been well recognized as a poor prognostic sign
(43). However, MRI measurements should theoretically be
more precise.
Other investigators have also used MRI to evaluate
different aspects of diastolic function. Kawaji et al. (44)
developed an automated method for quickly quantifying
LV volumes across the cardiac cycle and used the resul-
tant filling curves to generate diastolic filling indexes
(Fig. 9). This has been done previously with radionuclide
angiography. The MRI filling indexes correlated with
New York Heart Association functional class (p  0.004)
and had 90% specificity and 74% sensitivity for detecting
diastolic dysfunction defined by echocardiographic E/A
ratios.
Rijzewijk et al. (45) compared MRI-measured flow
through the mitral valve with a variety of parameters of
diastolic function, including E/A ratios and peak E-wave
deceleration. They compared findings between 78 men with
uncomplicated type 2 diabetes and 24 normoglycemic con-
trols and found that the patients with diabetes had signifi-
cantly elevated E/A ratios (p 0.003). They also performed
a comprehensive analysis of fatty metabolism with PET and
phosphorus metabolism with MRI spectroscopy and found
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April 26, 2011:1721–34 The Year in Cardiac Imagingincreased (p  0.021) fatty acid metabolism in the patients
ith diabetes.
Moreo et al. (46) compared known Doppler echocar-
iographic findings of diastolic dysfunction with MRI
ndings of myocardial fibrosis. In 252 subjects undergo-
ng Doppler echocardiography and MRI delayed en-
ancement imaging, including normal controls and pa-
ients with a variety of cardiomyopathies, patients with
iastolic dysfunction were more likely to have myocardial
brosis by MRI than patients without diastolic dysfunc-
ion (p  0.0001).
MRI-GUIDED RADIOFREQUENCY ABLATION. Catheter-based
adiofrequency ablation is increasingly used to treat refrac-
ory atrial fibrillation. Intraprocedural navigation of cathe-
ers is an area of intense interest; many investigators are
earching for imaging systems that would permit real-time,
-dimensional image guidance of the ablation procedure.
RI has definite advantages: a lack of ionizing radiation
nd excellent soft tissue contrast. However, the major
isadvantage of MRI has been the difficulty of creating
RI-compatible equipment, as the MRI scanner generates
continuous, strong magnetic field, which interferes with
he function of electronic equipment and potentially heats
Figure 9 Automated Calculation of LV Filling Curves by Magne
(A) Short-axis magnetic resonance images are shown in which an automated segm
represents a different anatomic level, with the top row showing basal images and
cardiac cycle, with the first and last columns representing end-diastole and the si
in green. (B) An LV filling curve is shown. On the right, the slope of the end-diasto
time to peak filling rate (TPFR) has been measured. On the left, the diastolic reco
recovery of 80% of the stroke volume (SV). (C) The slope of the LV filling curve is
with the peak E-wave greater than the A-wave. On the right, an abnormal curve froires and cables. mHoffmann et al. (47) developed an MRI-compatible
blation catheter, which they tested in 20 pigs. Catheter
osition was continually monitored with MRI: an inter-
entionalist guided the catheter while a second operator
ontinually adjusted the imaging planes to follow the
atheter. As ablation was performed in the right atrium,
he ablated right atrial tissue was detected with MRI
sing an edema-sensitive sequence. The procedure was
onsidered successful if MRI showed that a continuous
blation line had been created between the inferior aspect
f the tricuspid annulus and the insertion of the inferior
ena cava. Pigs subsequently went to electrophysiologic
esting and then to post-mortem gross examination to
valuate the ablation line.
In the 18 surviving pigs, the ablation line was complete
y MRI. In all 18 pigs, post-mortem gross examination
onfirmed the completeness of the ablation line, although
n 3 of these, electrophysiologic mapping suggested that
he block was incomplete. The investigators concluded
hat MRI navigation of radiofrequency ablation is feasi-
le but noted that translation of this work to humans will
equire further safety testing. This avenue of research is
romising for the development of 3-dimensional catheter
sonance Imaging
ion method has been used to measure left ventricular (LV) volumes. Each row
ttom row showing apical images. Columns represent different phases of the
lumn representing end-systole. LV volumes are measured from the areas colored
rtion of the curve has been measured to calculate a peak filling rate (PFR). The
lume (DVR) has been measured, which is the amount of time in diastole for
, which gives filling over time (flow). The left-hand curve shows normal LV flow
fferent patient is shown. Reprinted, with permission, from Kawaji et al. (44).tic Re
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Issues of utilization and appropriateness continued to attract
interest in both the scientific and health policy world.
Parker et al. (48) reported on the regional variation in all
noninvasive imaging (cardiac and noncardiac) over the past
decade in Medicare beneficiaries. The highest use region
(Atlanta) had approximately 50% more utilization of non-
invasive imaging than the lowest use region (Seattle). Some
of the highest regional variation occurred in noninvasive
cardiovascular imaging. Echocardiography and cardiovascu-
lar nuclear imaging had nearly twice as much utilization in
the highest use region compared with the lowest use region.
Cardiac MRI and cardiac CT both had more than 7 times
the utilization in the highest use region compared with the
lowest use region.
Appropriate use criteria, developed by the American
College of Cardiology Foundation in association with mul-
tiple other partners, are a response to concerns about
utilization. Prior studies of the application of appropriate
use criteria have come from single centers. Hendel et al. (49)
reported a large multicenter study that used a point-of-
service Internet-based tool on 6,351 patients at 6 centers.
Each of the sites that participated had access to online
reports of appropriate, uncertain, and inappropriate tests in
real time. However, only 4 of the 6 sites had sufficient data
to permit study of the potential changes in the rates of
inappropriate tests over 3 different time periods (Fig. 10).
One of these 4 sites, which had the highest rate of
inappropriate studies at baseline, reported a significant
decrease in inappropriate studies. The 5 most frequent
inappropriate indications accounted for the vast majority
(92%) of the inappropriate studies (Table 2); this finding
was very similar to previous single-center reports. This
Figure 10 Inappropriate Single Photon-Emission
Computed Tomographic Studies Over Time
The rate of any inappropriate studies is displayed for each of 4 different clini-
cal sites, with data collected over 3 different time periods. Reprinted, with per-
mission, from Hendel et al. (49).landmark study demonstrated the feasibility of trackingimaging appropriateness over time to target initiatives for
physician education and quality improvement.
Levin et al. (50) reported on the impact of a 3-tier prior
authorization program of a radiology benefits management
company on the utilization of MRI, CT, and PET. The rate
of growth of imaging appeared to slow with this program,
although accurate baseline data were not available.
Bourque et al. (51) reported a prospective analysis on
1,056 consecutive exercise SPECT patients that is likely to
influence future revisions of the appropriate use criteria. Of
the 1,056 study patients, 974 exceeded 85% of their maxi-
mum age-predicted heart rates. Of these 974 subjects,
almost one-half (473 [48.6%]) achieved at least 10 meta-
bolic equivalents of exercise. These patients had a very low
prevalence (0.4%) of ischemia (Fig. 11). There was no severe
ischemia (10% of the left ventricle) in the 430 patients
Most Frequent InappropriateIndications for SPECT Im gingTable 2 Most Frequent InappropriateIndications for SPECT Imaging
Indication
Inappropriate
Studies (%)
Detection of CAD, asymptomatic, low CHD 44.5
Asymptomatic, 2 yrs after PCI, symptoms before PCI 23.8
Evaluation of chest pain, low probability 16.1
Interpretable ECG, able to exercise
Asymptomatic/stable, known CAD 1 yr after catheterization
or abnormal SPECT findings
3.9
Pre-operative, low-risk surgery 3.7
Total 92.0
Reprinted, with permission, from Hendel et al. (49).
CAD coronary artery disease; CHD coronary heart disease risk according to Framingham risk
score; ECG  electrocardiogram; PCI  percutaneous coronary intervention; SPECT  single
photon-emission computed tomography.
Figure 11 Prevalence of Myocardial Ischemia
by Exercise Capacity
Nine hundred seventy-four subjects achieving 85% of their maximum age-
predicted heart rates, subgrouped by the exercise work load achieved in meta-
bolic equivalents (METs). The y-axis displays the percent of patients with a
given percent of myocardial (left ventricular [LV]) ischemia. Only 0.4% of
patients achieving at least 10 METs had myocardial ischemia of 10% of the
left ventricle. These patients both had ST-segment depression with exercise.
Reprinted, with permission, from Bourque et al. (51).
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Bourque et al. (51) suggested that the expense of SPECT
imaging could be avoided in 31% of all the patients in their
laboratory by not injecting tracer in subjects who reached
their target heart rates and 10 metabolic equivalents of
xercise without ischemic ST-segment depression.
Patel et al. (42) reported that only 37.6% of patients
ndergoing coronary angiography in the National Cardio-
ascular Data Registry had obstructive CAD and that a
positive result on a noninvasive test was only modestly
redictive.” However, 30% of the patients in this study were
symptomatic, and resting electrocardiography, echocardi-
graphy, and CT may have been included as noninvasive
ests, so the relevance of this study to stress imaging in
ymptomatic patients is unclear.
onclusions
e hope that this summary will inspire readers to examine
he important reports in more detail and to apply imaging
ore carefully within their practices.
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